Press Releases
DNA Electronics CEO Professor Chris Toumazou To Address Scripps “Future of Genomic Medicine” Conference
DNA Electronics Ltd. a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that DNA Electronics Chairman and CEO Professor Chris Toumazou...
Press Releases
Ferrer announces best-in-class results in phase I for Lorediplon in insomnia
Ferrer, a privately-held Spanish pharmaceutical company with full vertical integration from R&D to distribution, today announces that it has completed phase I clinical trials...
Press Releases
Pharmaceutical regulatory affairs specialist ELC Group establishes global HQ in Cambridge, UK
Cambridge, UK, February 8 2012 – ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, today formally announces that it has established its global headquarters...
Press Releases
RBCC Negotiates Funding Terms With n3D
Rainbow Biosciences, the biotech division of Rainbow Coral Corp. announced today that it’s on the cusp of a major breakthrough in its business relationship with...
Press Releases
Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral®-28 and Norgestrel Birth Control Pill Recall
Attorney Advertising. Keller Rohrback L.L.P. (www.krcomplexlit.com) is investigating possible consumer claims against Pfizer, Inc. relating to its recent recall of certain lots of Lo/Ovral®-28...
Press Releases
Histogenics Corporation to Present at Canaccord Genuity Musculoskeletal Conference
Histogenics Corporation, a privately held, regenerative medicine company, today announced that President and Chief Executive Officer Patrick O’Donnell will present at the upcoming Canaccord Genuity...
Press Releases
Alize Pharma licenses its ASPAREC(R) therapy for treatment of Acute Lymphoblastic Leukemia (ALL) to EUSA Pharma
Alize Pharma II, a drug development company focused on oncology and metabolism and part of the Alize Pharma group, announced today the signing of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.